ArticleActa physiologica (Oxford, England)2026
Citrate-Dependent Activation of Acetyl CoA Carboxylase Promotes Renal Lipid Accumulation in a Rat Model of Chronic Kidney Disease.
Article in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAbnormal accumulation of lipids within the kidney contributes to the progression of chronic kidney disease, but the underlying metabolic mechanisms remain unclear. Citrate is a central metabolite in cellular energy regulation and is frequently elevated in advanced kidney disease, yet its impact on renal lipid metabolism has not been investigated. This study tested whether increased circulating citrate promotes lipid accumulation in the kidney by activating acetyl-CoA carboxylase independently of adenosine monophosphate-activated protein kinase.
methodsMale Munich Wistar Frömter rats, a genetic model of chronic kidney disease, were studied together with HEK293 cells exposed to citrate. Protein expression, phosphorylation, and polymerization were assessed using western blotting, q-RT-PCR, and native gel electrophoresis. Renal lipid composition was characterized by untargeted high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry, and citrate levels were semi-quantified using capillary electrophoresis-time-of-flight mass spectrometry.
resultsMWF rats exhibited elevated plasma citrate, reduced vitamin D and bone mineral density, and increased renal fibrosis and mitochondrial dysfunction. Moreover, MWF showed higher expression of ATP-citrate lyase and fatty acid synthase, together with reduced phosphorylation of acetyl-CoA carboxylase and AMP-activated protein kinase, increased renal lipid deposition, and elevated fatty acid content. In HEK293, citrate treatment reproduced these effects, inducing acetyl-CoA carboxylase polymerization, lipid droplet formation, impaired mitochondrial activity, and increased superoxide production.
conclusionThis study identifies citrate-dependent activation of acetyl-CoA carboxylase as a driver of renal lipid accumulation and remodeling independently of AMP-activated protein kinase, revealing a novel metabolic mechanism linking systemic citrate to kidney injury and potential therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.